BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31846619)

  • 1. Charge-reversal nanocarriers: An emerging paradigm for smart cancer nanomedicine.
    Zhang M; Chen X; Li C; Shen X
    J Control Release; 2020 Mar; 319():46-62. PubMed ID: 31846619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge reversal nano-systems for tumor therapy.
    Zhang P; Chen D; Li L; Sun K
    J Nanobiotechnology; 2022 Jan; 20(1):31. PubMed ID: 35012546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
    Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
    Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in dual-responsive nanocarriers based on acid sensitivity for anticancer drug].
    Lu X; Guo X; Wan D; Pan J
    Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1723-1731. PubMed ID: 33164451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy.
    Fang Z; Pan S; Gao P; Sheng H; Li L; Shi L; Zhang Y; Cai X
    Int J Pharm; 2020 Feb; 575():118841. PubMed ID: 31812795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual pH/redox-responsive hyperbranched polymeric nanocarriers with TME-trigger size shrinkage and charge reversible ability for amplified chemotherapy of breast cancer.
    Badparvar F; Marjani AP; Salehi R; Ramezani F
    Sci Rep; 2024 Apr; 14(1):8567. PubMed ID: 38609391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress on charge-reversal polymeric nanocarriers for cancer treatments.
    Sun Q; Zhu Y; Du J
    Biomed Mater; 2021 May; 16(4):. PubMed ID: 33971642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
    Miao Y; Qiu Y; Yang W; Guo Y; Hou H; Liu Z; Zhao X
    Colloids Surf B Biointerfaces; 2018 Sep; 169():313-320. PubMed ID: 29800906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagenase-loaded pH-sensitive nanocarriers efficiently remodeled tumor stroma matrixes and improved the enrichment of nanomedicines.
    Wang J; Wu Q; Wang Y; Xiang L; Feng J; Zhou Z; Fu Q; Zhang L
    Nanoscale; 2021 May; 13(20):9402-9414. PubMed ID: 34002757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles.
    Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN
    ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge-conversional and pH-sensitive PEGylated polymeric micelles as efficient nanocarriers for drug delivery.
    Liu GY; Li M; Zhu CS; Jin Q; Zhang ZC; Ji J
    Macromol Biosci; 2014 Sep; 14(9):1280-90. PubMed ID: 24866398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trigger responsive polymeric nanocarriers for cancer therapy.
    Kaur S; Prasad C; Balakrishnan B; Banerjee R
    Biomater Sci; 2015 Jul; 3(7):955-87. PubMed ID: 26221933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.